Phase I/II clinical trial of immunoRFA with OK-432 for patients with lung cancer
Phase 1
- Conditions
- lung cencer(lung neoplasms)
- Registration Number
- JPRN-UMIN000007167
- Lead Sponsor
- Osaka City University, Department of Diagnostic and Interventional Radiology, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Not provided
Exclusion Criteria
The following patients must be excluded: 1)Patients with bleeding tendency 2)Patients who cannot take a CAT scan 3)Patients with the past history of severe allergic reactions for OK-432 4)Patients with the past history of severe allergic reactions for Penicillin 5)Patients who are judged inappropriate for the clinical trial by doctors.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method